CURRENT AFFAIRS

Detailed explanation-1: -900 Crore for the Mission COVID Suraksha- The Indian COVID-19 Vaccine Development Mission.

Detailed explanation-2: -0, for promoting research and development of Indian COVID-19 vaccines. Mission COVID Surakshais being led by the Department of Biotechnology (DBT) and is being implemented by Biotechnology Industry Research Assistance Council (BIRAC), a Public Sector Undertaking (PSU) of DBT, at a total cost of Rs. 900 Cr.

Detailed explanation-3: -What technology has been used in the development of the currently available two vaccines in India? vaccine, manufactured by the Serum Institute of India, is a Viral Vector based Technology which is also used to manufacture the Ebola vaccine.

Detailed explanation-4: -COVAXIN®, India’s indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).

Detailed explanation-5: -Developed by Bharat Biotech in collaboration with the Indian Medical Research Council (ICMR) and National Institute of Virology (NIV), COVAXIN™ (BBV152) is India’s first indigenous, whole-virion, inactivated vaccine for the treatment of the highly infectious disease Covid-19.